Meropenem and Cirrhosis alcoholic - a phase IV clinical study of FDA data

Summary:

Cirrhosis alcoholic is reported only by a few people who take Meropenem.

The phase IV clinical study analyzes which people take Meropenem and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 22,665 people who have side effects while taking Meropenem from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 26, 2022

22,665 people reported to have side effects when taking Meropenem.
Among them, 4 people (0.02%) have Cirrhosis alcoholic.


What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 22,708 Meropenem users for its effectiveness, alternative drugs and more.

What is Cirrhosis alcoholic?

Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 364 drugs and 162 conditions by eHealthMe.

Number of Meropenem and Cirrhosis alcoholic reports submitted per year:

Could Meropenem cause Cirrhosis alcoholic?

Time on Meropenem when people have Cirrhosis alcoholic *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cirrhosis alcoholic when taking Meropenem *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Cirrhosis alcoholic when taking Meropenem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Meropenem *:

  1. Orgaran: 3 people, 75.00%
  2. Cubicin: 2 people, 50.00%
  3. Tolvaptan: 1 person, 25.00%
  4. Seroquel: 1 person, 25.00%

Common side effects people have besides Cirrhosis alcoholic *:

  1. Renal Impairment (severely reduced kidney function): 4 people, 100.00%
  2. White Blood Cell Count Increased: 3 people, 75.00%
  3. Drug Ineffective: 3 people, 75.00%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 2 people, 50.00%
  5. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 25.00%
  6. Multi-Organ Failure (multisystem organ failure): 1 person, 25.00%
  7. Clostridium Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 25.00%

Common conditions people have *:

  1. Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria): 3 people, 75.00%
  2. Pvt: 2 people, 50.00%
  3. Infectious Pleural Effusion (infectious fluid in the lung): 2 people, 50.00%
  4. Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 50.00%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 25.00%
  6. Clostridium Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Cirrhosis alcoholic?

Check whether Cirrhosis alcoholic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Cirrhosis alcoholic and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Alternative drugs to, pros and cons of Meropenem:

Common Meropenem side effects:

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Cirrhosis alcoholic treatments and more:

COVID vaccines that are related to Cirrhosis alcoholic:

All the drugs that are associated with Cirrhosis alcoholic:

All the conditions that are associated with Cirrhosis alcoholic:

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: